Hikma Pharmaceuticals Plc (HKMPF)

Last Closing Price: --

Company Description

Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $3.13B
Net Income (Most Recent Fiscal Year) $359.00M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.19
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 11.30
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) --
Return on Assets (Trailing 12 Months) --
Current Ratio (Most Recent Fiscal Quarter) 1.24
Quick Ratio (Most Recent Fiscal Quarter) 0.72
Debt to Common Equity (Most Recent Fiscal Quarter) 0.33
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $10.46
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange --
Sector --
Industry --
Common Shares Outstanding 221.89M
Free Float --
Market Capitalization $5.59B
Average Volume (Last 20 Days) 483.40
Beta (Past 60 Months) 0.54
Percentage Held By Insiders (Latest Annual Proxy Report) --
Percentage Held By Institutions (Latest 13F Reports) 0.00%
Annual Dividend (Based on Last Quarter) $0.72
Dividend Yield (Based on Last Quarter) 2.86%